Vitruvias Therapeutics
Manufacturing · Alabama, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
778 N Dean Rd Ste 600, Auburn, Alabama, ...Phone Number
(334) 329-5601Website
www.vitruvias.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Vitruvias Therapeutics
Vitruvias Therapeutics specializes in the development and distribution of generic and authorized generic drugs. The company partners with small global pharmaceutical companies to navigate the U.S. generic market effectively. Their product offerings include various medications such as Aminocaproic Acid Tablets and Bupropion Hydrochloride Extended-Release Tablets. With a focus on strategic partnerships and integrity, Vitruvias aims to connect international products with American markets.Explore more
Vitruvias Therapeutics Org Chart
EM
Chief Financial Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vitruvias Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Vitruvias Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Vitruvias Therapeutics
Vitruvias Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Vitruvias Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Vitruvias Therapeutics has new funding data
Check if Vitruvias Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Vitruvias Therapeutics recently announced quarterly report
Click to see if Vitruvias Therapeutics had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Vitruvias Therapeutics
Compare insights from companies similar to Vitruvias Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vitruvias Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vitruvias Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vitruvias Therapeutics.
Vitruvias Therapeutics financials insights
Gather financial insights about Vitruvias Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Private Equity
$750K
2017
Series A
$11.5M
2020
Debt
$150K
2021
Debt
$208K
Vitruvias Therapeutics Tech Stack
A closer look at the technologies used by Vitruvias Therapeutics
See more technologies
Most Recent Scoops
Person-Based
Event
Events
Funding
Vitruvias Therapeutics has received an SBA PPP loan in the amount of $208,333 from MAX CU resulting in the retention of 10 jobs.
Funding
Vitruvias Therapeutics has received an SBA PPP loan for $150,000-350,000 from MAX CU, supporting the retention of 14 jobs.
Partnership
Vitruvias Therapeutics News & Media
Vitruvias Therapeutics Inc. Launches Shanghai-Based Sinotherapeutics’s Approved Version of Propafenone ER in the U.S.
AUBURN, Ala. & SHANGHAI--(BUSINESS WIRE)--Vitruvias Therapeutics Inc., an Auburn, Alabama-based finished-dose generic drug company, and Sinotherapeutics Inc., a Shanghai-based generic drug company, announced they have launched a bioequivalent FDA-approved version of Rythmol SR. Rythmol SR, known generically as propafenone hydrochloride, is an antiarrhythmic drug supplied in extended-release capsules of 225, 325 and 425 mg for oral administration. It is indicated for the treatment of sustaineVitruvias Therapeutics Inc. Enters into a Semi-Solid (Topical) Licensing Agreement with Hong Kong-Based Bright Future
AUBURN, Ala. & HONG KONG--(BUSINESS WIRE)--Vitruvias Therapeutics Inc., an Auburn, Alabama-based finished-dose generic drug company, has announced it has entered into a collaborative development agreement with a Hong Kong-based pharmaceutical company, Bright Future Pharmaceutical Lab Ltd, to develop a portfolio of semi-solids to be marketed in the United States and China. U.S. distribution will be handled by Vitruvias and Bright Future will be responsible for China and other agreed upon AsiaVitruvias Therapeutics Inc., Licenses Potassium Chloride ER ANDA (10 and 20 mEq) Capsules to Be Manufactured at Bora Pharmaceutical’s New Zhunan Facility in Taiwan
AUBURN, Ala. & TAIPEI, Taiwan--(BUSINESS WIRE)--Vitruvias Therapeutics Inc., an Auburn, Alabama-based finished-dose generic drug development company, has agreed to license an approved Potassium Chloride Extended release ANDA. The product will be manufactured by Bora Pharmaceutical’s Zhunan site, which was recently acquired from Impax. Carl Whatley, Chairman and CEO of Vitruvias stated that “as a 40-year veteran if this industry, I have toured many manufacturing facilities, and Bora’s Zhunan facVitruvias Therapeutics Inc., and Sunny Pharmtech Inc., Announce the FDA Approval of Generic Aminocaproic Acid 500 mg and 1000 mg Tablets
AUBURN, Ala. & TAIPEI, Taiwan--(BUSINESS WIRE)--Generic Aminocaproic Acid Approval for Vitruvias Therapeutics and Sunny Pharmtech
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vitruvias Therapeutics
Sign Up For FreeTo access detailed company insights
Vitruvias Therapeutics specializes in the development and distribution of generic and authorized generic drugs. The company partners with small global pharmaceutical companies to navigate the U.S. generic market effectively. Their product offerings include various medications such as Aminocaproic Acid Tablets and Bupropion Hydrochloride Extended-Re... Read More
